
Purity & Potency Analysis
Reverse-phase HPLC and UHPLC purity quantification with impurity profiling to sub-0.1% detection, calibrated to USP/ICH specifications. UV/DAD detection with optional mass-directed collection for structural confirmation.
GLP-compliant methodology. Validated methods for every compound class. IND/DMF-ready documentation. Signed Certificate of Analysis with every result.

Reverse-phase HPLC and UHPLC purity quantification with impurity profiling to sub-0.1% detection, calibrated to USP/ICH specifications. UV/DAD detection with optional mass-directed collection for structural confirmation.

High-resolution ESI-MS for complete sequence confirmation, post-translational modification (PTM) detection, disulfide mapping, and structural verification of complex peptide architectures.

Accelerated and real-time stability programs under controlled conditions — complete data packages for IND and CMC submissions. Photostability, thermal stability, and freeze-thaw cycling available.

USP <71> sterility testing and LAL-based endotoxin / BET detection for injectable-grade peptides and research formulations. GLP-compliant, CoA-ready documentation for regulatory submissions.

Quantitative amino acid composition confirming sequence integrity, detecting deletions or substitutions, supporting lot-to-lot consistency. Chiral purity and D/L ratio assessment available.

Methods for cyclic, stapled, PEGylated, phosphorylated, glycosylated, and D-amino acid peptides. Contact us to scope your project and discuss your compound class and regulatory requirements.
Independent analytical testing for 91+ research peptides, blends, and bioregulators across 12 categories. Every report is scientist-reviewed and ships with a signed Certificate of Analysis you can verify.
Answers to the questions we hear most often from research teams, formulators, and regulatory groups submitting peptides for analysis.